Overview

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fasting condition in normal, healthy, adult human subjects.
Phase:
Phase 1
Details
Lead Sponsor:
IPCA Laboratories Ltd.
Treatments:
Bisoprolol